Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Vaarst | 2022 | Series B | $19.9M | Bristol |
| Rovco | 2022 | Series B | $20.0M | Bristol |
| Prism Network Ltd | 2022 | Convertible Note | Undisclosed | Leicester |
| Helix Geospace/Helix Technologies | 2021 | Seed | $4.0M | Harwell |
| Synthace | 2021 | Series C | $35.0M | London |
| Orbit Discovery | 2021 | Seed | $7.6M | Oxford |
| Aria Pharmaceuticals | 2021 | Series B | Undisclosed | Palo Alto |
| Akrivia Health | 2021 | Series A | $5.9M | Oxford |
| Zipabout | 2021 | Series A | Undisclosed | Birmingham |
| AgPlus diagnostics | 2021 | Seed | $1.4M | Bedford |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 101 | Vaarst | Series B | $19.9M | Bristol, United Kingdom |
| 102 | Rovco | Series B | $20.0M | Bristol, United Kingdom |
| 103 | Prism Network Ltd | Convertible Note | Undisclosed | Leicester, United Kingdom |
| 104 | Helix Geospace/Helix Technologies | Seed | $4.0M | Harwell, United Kingdom |
| 105 | Synthace | Series C | $35.0M | London, United Kingdom |
| 106 | Orbit Discovery | Seed | $7.6M | Oxford, United Kingdom |
| 107 | Aria Pharmaceuticals | Series B | Undisclosed | Palo Alto, United States |
| 108 | Akrivia Health | Series A | $5.9M | Oxford, United Kingdom |
| 109 | Zipabout | Series A | Undisclosed | Birmingham, United Kingdom |
| 110 | AgPlus diagnostics | Seed | $1.4M | Bedford, United Kingdom |
Vaarst develops robotic analytic solutions for marine applications.
Rovco provides an autonomous underwater vehicle and remotely operated underwater vehicle technologies and support services.
Prism Network Ltd provides disaster recovery and building repair service to insurance and property sectors in the United Kingdom.
Helix Geospace is developing a range of compact, high-performance, dielectric-loaded ceramic antennas and systems.
Synthace is a SaaS Life Sciences R&D Digital Experiment Platform.
Orbit Discovery is a peptide display company identifying potential peptide drugs for a range of chronic diseases.
Aria Pharmaceuticals is a artificial intelligence-driven biopharmaceutical company.
Real-world data and evidence, clinical trial optimisation and molecular characterisation for mental health and dementias
Zipabout offers invaluable knowledge and insight to policy-makers, transport operators and travellers.
Ag+ has been to deliver a rapid diagnostic platform technology .
Oneskee is a designer and retailer of ski wear.
Lazy Flora delivers hassle-free container gardens to busy people in the UK,
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies for infectious diseases and cancer.
NorthRow helps businesses to efficiently protect themselves from financial crime, from failures to comply with related legislation.
Keit’s microFTS® design is a Fourier Transform Infrared spectrometer that is smaller, lighter and more rugged than any current system.
PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.
Arctoris is a tech-enabled platform company in biotechnology, combining robotics & data science to accelerate drug discovery.
Spectral Edge combines patented Image Fusion tech with Deep Learning to reveal more of the color, detail and clarity in any image.
Webmoco is provides software design and development solutions for companies in the United Kingdom and internationally.
Jupiter Diagnostics has developed a diagnostic platform
Breaking Free Online Limited is a digital health company focused on solutions for substance misuse.
Amba is a new entry into the Defence & Security market, with a focus on delivering bespoke solutions to high-level end users.
Etive which is expanding its Birmingham operations, is capitalising on the government's desire to move all public services online.
Future Planet Capital has invested in 123 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Future Planet Capital's top investment sectors include Biotechnology, Health Care, Artificial Intelligence (AI), Pharmaceutical, Software. The firm invests across 53 different industry categories.
Among tracked funding rounds, Barinthus Biotherapeutics received $168.0M in a Series B round. Future Planet Capital's total known invested capital is $818.8M.
Future Planet Capital's average investment size is $11.1M across its portfolio of 123 companies.
Recent Future Planet Capital portfolio additions include Vaarst, Rovco, Prism Network Ltd, Helix Geospace/Helix Technologies, Synthace. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors